等待開盤 11-07 09:30:00 美东时间
-0.320
-2.87%
CorMedix Inc., a biopharmaceutical company focused on developing therapies for life-threatening conditions, will participate in the Jefferies Global Healthcare Conference in New York on June 3-5, 2025. The company will present on June 5, 2025, at 3:45 p.m. EDT. CorMedix, which commercialized its lead product DefenCath® (taurolidine and heparin) in inpatient and outpatient settings, is expanding its clinical studies into adult TPN and pediatric HD...
05-30 12:30